NMC Health (NMC) Receives “Buy” Rating from Berenberg Bank
NMC Health (LON:NMC)‘s stock had its “buy” rating reiterated by Berenberg Bank in a note issued to investors on Wednesday. They currently have a GBX 4,000 ($53.84) price objective on the stock. Berenberg Bank’s price target would suggest a potential upside of 44.98% from the stock’s current price.
Separately, Jefferies Group reiterated a “hold” rating and issued a GBX 2,810 ($37.82) price target on shares of NMC Health in a report on Wednesday, November 15th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. NMC Health presently has a consensus rating of “Buy” and an average target price of GBX 2,522 ($33.94).
Shares of NMC Health (LON:NMC) opened at GBX 2,759 ($37.13) on Wednesday. NMC Health has a twelve month low of GBX 1,406 ($18.92) and a twelve month high of GBX 3,211 ($43.22).
About NMC Health
NMC Health plc is a private healthcare services provider in the United Arab Emirates. The Company operates through two segments: healthcare and distribution & services. The healthcare segment is engaged in providing professional medical services, comprising diagnostic services, in and outpatient clinics, provision of all types of research and medical services in the field of gynecology, obstetrics and human reproduction and retailing of pharmaceutical goods.
Receive News & Ratings for NMC Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NMC Health and related companies with MarketBeat.com's FREE daily email newsletter.